Macrogenics reported $142.48M in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Amgen AMGN:US $ 2419M 1503M
AstraZeneca AZN:LN 2951310.75M 184237.79M
Biogen BIIB:US $ 11872.5M 630.2M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Cerulean Pharma CERU:US $ 30.88M 7.88M
Daiichi Sankyo 4568:JP Y 1400252M 49380M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Epizyme EPZM:US $ -20.28M 31.4M
Genmab GEN:DC DK 24482M 1763M
Geron GERN:US $ 142.05M 44.56M
Gilead Sciences GILD:US $ 20215M 288M
Immunogen IMGN:US $ 249.83M 56.64M
Karyopharm Therapeutics KPTI:US $ -116338000 33.26M
Macrogenics MGNX:US $ 142.48M 35.73M
Puma Biotechnology PBYI:US $ 19.74M 12.59M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
Xencor XNCR:US $ 742.34M 20.68M